Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia

Michele S. Redell(Baylor College of Medicine)

Clinical & Translational Oncology

May 4, 2021

10.1007/s12094-021-02621-w

Cited by 8

Related Papers

Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor

|Blood|2011|261

DOT1L Inhibition Sensitizes MLL-Rearranged AML to Chemotherapy

|PLoS ONE|2014|73

Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated

|Cancers|2023|18